Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer

doi:10.3748/wjg.v30.i39.4281

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (95)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-4)

Sum=57

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=32

Publishing Process of This Article

Item

Count

Browse

Download

Sum=2

Oct 21, 2024 (publication date) through Oct 13, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 21, 2024; 30(39): 4281-4294
Published online Oct 21, 2024. doi: 10.3748/wjg.v30.i39.4281

Table 3 Univariate and multivariate Cox regression analysis of ampulla of Vater cancer

Characteristics	Univariate		Multivariate
Characteristics	HR (95%CI)	P value	HR (95%CI)	P value
Sex (male/female)	1.079 (0.600-1.938)	0.800
Age (≤ 60/> 60), year	0.877 (0.485-1.586)	0.664
BMI, kg/m²
< 18.5		Reference
18.5-24	1.256 (0.298-5.298)	0.756
> 24	1.876 (0.414-8.494)	0.414
Diabetes (yes/no)	1.048 (0.253-4.348)	0.949
Neutrophil count (≤ 5.39/> 5.39), × 10⁹/L	2.434 (0.961-6.168)	0.061
Lymphocyte count (≤ 1.21/> 1.21), × 10⁹/L	1.812 (1.006-3.262)	0.048^a	1.849 (0.969-3.529)	0.062
Blood platelet count (≤ 165/> 165), × 10⁹/L	2.083 (1.074-4.039)	0.030^a	1.791 (0.893-3.591)	0.101
Albumin (≤ 38.45/> 38.45), g/L	1.840 (1.015-3.336)	0.045^a	2.387 (1.247-4.569)	< 0.01^a
ALT (≤ 283/> 283), U/L	0.369 (0.114-1.192)	0.096
AST (≤ 277/> 277), U/L	0.437 (0.106-1.803)	0.252
Tbil (≤ 28.4/> 28.4), μmol/L	0.440 (0.205-0.945)	0.035^a	0.343 (0.143-0.825)	0.017^a
NLR (≤ 5.90/> 5.90)	0.181 (0.025-1.315)	0.091
PLR (≤ 186.6/> 186.6)	0.737 (0.408-1.332)	0.312
PNI (≤ 44.6/> 44.6)	0.664 (0.363-1.214)	0.183
CA19-9 (≤ 37.54/> 37.54), U/mL	1.258 (0.690-2.291)	0.454
ASA
I		Reference
II	0.536 (0.223-1.288)	0.163
III	0.633 (0.225-1.786)	0.388
T stage
T1		Reference
T2	1.641 (0.811-3.321)	0.168
T3	1.354 (0.392-4.679)	0.632
N stage
N0		Reference
N1	1.389 (0.642-3.005)	0.404
N2	1.524 (0.355-6.529)	0.571
TNM stage
I		Reference
II	1.142 (0.516-2.526)	0.743
III	2.413 (0.959-6.072)	0.061
Duration of surgery (≤ 368/> 368), min	0.853 (0.471-1.544)	0.599
Intraoperative blood loss (280 ≤ /> 280), mL	0.895 (0.464-1.726)	0.741
Tumor size (≤ 1.99/> 1.99), cm	0.475 (0.210-1.072)	0.073
Number of positive lymph nodes (≤ 1/≥ 2)	0.407 (0.208-0.796)	< 0.01^a	0.375 (0.189-0.745)	< 0.01^a
Adjuvant therapy (yes/no)	0.988 (0.475-2.053)	0.974

^aP < 0.05.

BMI: Body mass index; Tbil: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NLR: Neutrophil to lymphocyte ratio; PLR: Platelet to lymphocyte ratio; PNI: Prognostic nutritional index; ASA: American Society of Anesthesiologists; AVC: Ampulla of Vater cancer; DPC: Duodenal papilla cancer.

Citation: Zhang JZ, Zhang ZW, Guo XY, Zhu DS, Huang XR, Cai M, Guo T, Yu YH. Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer. World J Gastroenterol 2024; 30(39): 4281-4294
URL: https://www.wjgnet.com/1007-9327/full/v30/i39/4281.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i39.4281